Skip to main content
Log in

Immune response to staphylococcal superantigens

  • Published:
Immunologic Research Aims and scope Submit manuscript

Abstract

Staphylococcal exotoxins, staphylococcal enterotoxins A-E (SEA-SEE), and toxic shock syndrome toxin-1 (TSST-1) are potent activators of the immune system and cause a variety of diseases in humans, ranging from food poisoning to shock. These toxins are called superantigens because of their ability to polyclonally activate T cells at picromolar concentrations. Superantigens bind to both MHC class II molecules and specific Vβ regions of the T cell receptor, leading to the activation of both antigen-presenting cells and T lymphocytes. These interactions lead to excessive production of proinflammatory cytokines and T cell proliferation, causing clinical symptoms that include fever, hypotension, and shock. Recent studies suggest that staphylococcal superantigens may also be involved in the pathogenesis of arthritis and other autoimmune disorders. This review summarizes the in vitro and in vivo effects of staphylococcal enterotoxins and TSST-1, recent progress with the use of transgenic knockout mice to identify key mediators and receptors involved in superantigen-induced shock, and therapeutic agents to mitigate the toxic effects of staphylococcal superantigens.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kotzin BL, Leung DYM, Kappler J, Marrack PA: Superantigens and their potential role in human disease. Adv Immunol 1993;54:99–166.

    PubMed  CAS  Google Scholar 

  2. Marrack P, Kappler J: The staphylococcal enterotoxins and their relatives. Science 1990;248:705–709.

    Article  PubMed  CAS  Google Scholar 

  3. Choi Y, Kotzin B, Hernon L, Callahan J, Marrack P, Kappler J: Interaction ofStaphylococcus aureus toxin “superantigens” with human T cells. Proc Natl Acad Sci USA 1989;86: 8941–8945.

    Article  PubMed  CAS  Google Scholar 

  4. Irwin MJ, Gascoigne NRJ: Interplaybetween superantigens and the immune system. J Leuk Biol 1993, 54:495–503.

    CAS  Google Scholar 

  5. Webb SR, Gascoigne NRJ: T cell activationby superantigens. Curr Opinion Immunol 1994; 6:467–475.

    Article  CAS  Google Scholar 

  6. Blackman MA, Woodland DL: In vivo effects of superantigens. Life Sci 1995;57:1717–1735.

    Article  PubMed  CAS  Google Scholar 

  7. Johnson HM, Torres BA, Soos JM: Superantigens: Structure and relevance to human disease. Proc Soc Exp Biol Med 1996;212:99–109.

    PubMed  CAS  Google Scholar 

  8. Florquin S, Aaldering L: Superantigens: a tool to gain new insight into cellular immunity. Res Immunol 1997;148:373–386.

    Article  PubMed  CAS  Google Scholar 

  9. Singh BR, Evenson ML, Bergdoll MS: Structural analysis of staphylococcal enterotoxin B and C1 using circular dichroism and fluorescence spectroscopy. Biochem 1998;27:8735–8741.

    Google Scholar 

  10. Swaminathan S, Furey W, Pletcher J, Sax M: Crystal structure of staphylococcal enterotoxin B, a superantigen. Nature 1992;359:801–806.

    Article  PubMed  CAS  Google Scholar 

  11. Acharya KR, Passalacqua EF, Jones EY, et al.: Structural basis of superantigen action inferred from crystal structure of TSST-1. Nature 1994;367:94–97.

    Article  PubMed  CAS  Google Scholar 

  12. Kappler JW, Herman A, Clements J, Marrack P: Mutations defining functional regions of the superantigen staphylococcal enterotoxin B. J Exp Med 1992;175:387–396.

    Article  PubMed  CAS  Google Scholar 

  13. Mollick JA, Chintagumpala M, Cook RG, Rich RR: Staphylococcal exotoxin activation of T cells: role of exotoxin-MHC class II binding affinity and class II isotype. J Immunol 1991;146:436–468.

    Google Scholar 

  14. Yagi J, Rath JS, Janeway CA: Control of T cell responses to staphylococcal enterotoxins by stimulator cell MHC class II polymorphism. J Immunol 1991;147:1398–1405.

    PubMed  CAS  Google Scholar 

  15. Herrmann T, Acolla RS, MacDonald HR:Different staphylococcal enterotoxins bind preferentially to distinct MHC class II isotypes. Eur J Immunol 1989;19:2171–2174.

    Article  PubMed  CAS  Google Scholar 

  16. Herman A, Croteau G, Sekaly RP, Kappler J, Marrack P: HLA-DR alleles differ in their ability to present staphylococcal enterotoxins to T cells. J Exp Med 1990;172: 709–712.

    Article  PubMed  CAS  Google Scholar 

  17. Chintagumpala MM, Mollick JA, Rich RR: Staphylococcal toxins bind to different sites on HLA-DR. J Immunol 1991;147:3876–3882.

    PubMed  CAS  Google Scholar 

  18. Thibodeau J, Cloutier I, Lavoie PM, et al.: Subsets of HLADR1 molecules defined by SEB and TSST-1 binding. Science 1994;266: 1874–1878.

    Article  PubMed  CAS  Google Scholar 

  19. Jardetzky TS, Brown JH, Gorga JC, et al.: Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature 1994;368:711–718.

    Article  PubMed  CAS  Google Scholar 

  20. Kim J, Urban RG, Strominger JL, Wiley DC: Toxic shock syndrome toxin-1 complexed with a class II MHC molecule HLADR1. Science 1994;2667:1870–1874.

    Article  Google Scholar 

  21. Hudson KR, Tiedemann RE, Urban RG, Lowe SC, Strominger JL, Fraser JD: Staphylococcal enterotoxin A has two cooperative binding sites on major histocompatibility complex class II. J Exp Med 1995;182:711–720.

    Article  PubMed  CAS  Google Scholar 

  22. Abrahmsen L, Dohlsten M, Segren S, et al.: Characterization of two distinct MHC class II binding sites in the superantigen staphylococcal enterotoxin A. EMBO J 1995;14:2978–2986.

    PubMed  CAS  Google Scholar 

  23. Tiedemann RE, Fraser JD: Crosslinking of MHC class II molecules by staphylococcal enterotoxin A is essential for antigen-presenting cell and T cell activation. J Immunol 1996;157:3958–3966.

    PubMed  CAS  Google Scholar 

  24. Thibodeau J, Dohlsten M, Cloutier I, et al.: Molecular characterization and role in T cell activation of staphylococcal enterotoxin A binding to the HLADR-α chain. J Immunol 1997;158:3698–3704.

    PubMed  CAS  Google Scholar 

  25. Kozono H, Parker D, White J, Marrack P, Kappler J: Multiple binding sites for bacterial superantigens on soluble class II MHC molecules. Immunity 1995; 3:187–196.

    Article  PubMed  CAS  Google Scholar 

  26. Ulrich RB, Bavari S, Olson MA: Staphylococcal enterotoxins A and B share a common structural motif for binding class II MHC molecules. Nature Struct Biol 1995; 2:554–560.

    Article  PubMed  CAS  Google Scholar 

  27. Mehindate K, Thibodeau J, Dohlsten M, et al.: Cross-linking MHC class II molecules by staphylococcal enterotoxin A superantigen is a requirement for inflammatory cytokine gene expression. J Exp Med 1995;182:1573–1577.

    Article  PubMed  CAS  Google Scholar 

  28. Gascoigne NRJ, Ames KT: Direct binding of secreted TCR β chain to superantigen associated with MHC class II complex protein. Proc Natl Acad Sci USA 1991; 88:613–616.

    Article  PubMed  CAS  Google Scholar 

  29. Newton DW, Dohlsten M, Olsson C, Segren S, Lundin KE, Land, P, Kalland T, Kotb M: Mutations in the MHC class II binding domains of SEA differentially affect T cell receptor Vβ specificity. J Immunol 1996;157:3988–3994.

    PubMed  CAS  Google Scholar 

  30. Surman S, Deckhut AM, Blackman MA, Woodland DL: MHC-specific recognition of a bacterial superantigen by weakly reactive T cells. J Immunol 1994; 152:4893–4902.

    PubMed  CAS  Google Scholar 

  31. Leder L, Liera A, Lavoie PM et al: A mutational analysis of the binding of staphylococcal enterotoxins B and C3 to the T cell receptor β chain and MHC class II. J Exp Med 1998;187:823–830.

    Article  PubMed  CAS  Google Scholar 

  32. Blackman MA, Smith HP, Le P, Woodland DL: Influence of the T cell receptor α-chain on T cell reactivity and tolerance to Mls-1 in T cell receptor β-chain transgenic mice. J Immunol 1993;151: 556–565.

    PubMed  CAS  Google Scholar 

  33. Linsley PS, Ledbetter JA: The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 1993;11:191–212.

    PubMed  CAS  Google Scholar 

  34. Fraser J, Newton M, Weiss A: CD28 and T-cell antigen receptor signal transduction coordinately regulates interleukin 2 gene expression in response to superantigen stimulation. J Exp Med 1992;175:1131–1134.

    Article  PubMed  CAS  Google Scholar 

  35. Krakauer T: Costimulatory receptors for the superantigen staphylococcal enterotoxin B on human vascular endothelial cells and T cells. J Leuko Biol 1994;56:458–463.

    PubMed  CAS  Google Scholar 

  36. Chatila T, Geha RS: Signal transduction by microbial superantigens via MHC class II molecules. Immunol Rev 1993;131:43–59.

    Article  PubMed  CAS  Google Scholar 

  37. LaSalle JM, Toneguzzo F, Saadeh M, et al.: T cell presentation of antigen requires cell to cell contact for proliferation and anergy induction. J Immunol 1993;151:649–657.

    PubMed  CAS  Google Scholar 

  38. Scholl PR, Trede N, Chatila TA, Geha RS: Role of protein tyrosine phosphorylation in monokine induction by the staphylococcal superantigen TSST-1. J Immunol 1992;148:2237–2243.

    PubMed  CAS  Google Scholar 

  39. Krakauer T: The induction of CC chemokines in human peripheral blood mononuclear cells by staphylococcal exotoxins and its prevention by pentoxifylline. J Leuk Biol 1999; 66:158–164.

    CAS  Google Scholar 

  40. Krakauer T: Inhibition of toxic shock syndrome toxin-induced cytokine production and T cell activation by interleukin 10, interleukin 4, and dexamethasone. J Infect Dis 1994;172:988–992.

    Google Scholar 

  41. Jupin C, Anderson S, Damais C, Alouf JE, Parant M: Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factors and gamma interferon. J Exp Med 1988;167:752–761.

    Article  PubMed  CAS  Google Scholar 

  42. Parsonnet J, Hickman RK, Eardley DD, Pier GB: Induction of human interleukin-1 by toxic shock syndrome toxin-1. J Infect Dis 1985;151:514–522.

    PubMed  CAS  Google Scholar 

  43. Grossman D, Cook RG, Sparrow JT, Mollick JA, Rich RR: Dissociation of the stimulatory activities of staphylococcal enterotoxins for T cells and monocytes. J Exp Med 1990;172:1831–1836.

    Article  PubMed  CAS  Google Scholar 

  44. Krakauer T: IL-8 production in human monocytic cells in response to staphylococcal exotoxins is direct and independent of IL-1 and TNFα. J Infect Dis 1998; 178:573–577.

    PubMed  CAS  Google Scholar 

  45. Trede NS, Geha RS, Chatila T: Transcriptional activation of ILlβ and TNF-α genes by MHC class II ligands. J Immunol 1991; 146:2310–2315.

    PubMed  CAS  Google Scholar 

  46. Fischer H, Dohlsten M, Andersson U, Hedlund G, Ericsson P, Hansson J, Sjogren HO: Production of TNF-α and TNF-β by staphylococcal enterotoxin A activated human T cells. J Immunol 1990;144:4663–4668.

    PubMed  CAS  Google Scholar 

  47. Carlsson R, Fischer H, Sjogren HO: Binding of staphylococcal enterotoxin A to accessory cells is a requirement for its ability to activate human T cells. J Immunol 1988;140:2484–2488.

    PubMed  CAS  Google Scholar 

  48. Lagoo A, Lagoo-Deenadayalan S, Lorenz H, Byrne J, Barber W, Hardy K: IL-2, IL-4, and IFNγ gene expression versus secretion in superantigen-activated T-cells. Distinct requirement for costimulatory signals through adhesion molecules. J Immunol 1994;152:1641–1652.

    PubMed  CAS  Google Scholar 

  49. Lando P, Olsson C, Kalland T, Newton D, Kotb M, Dohlsten M: Regulation of superantigen-induced T-cell activation in the absence and the presence of MHC class II. J Immunol 1996;157: 2857–2863.

    PubMed  CAS  Google Scholar 

  50. Hewitt C, Lamb J, Hayball J, Hill M, Owen M, O’Hehir R: MHC Independent clonal T cell anergy by direct interaction of staphylococcal enterotoxin B with the T-cell antigen receptor. J Exp Med 1992;175:1493–1499.

    Article  PubMed  CAS  Google Scholar 

  51. Avery A, Markowitz J, Grusby M, Glimcher L, Cantor H: Activation of T cells by superantigen in class II-negative mice. J Immunol 1994;153:4853–4861.

    PubMed  CAS  Google Scholar 

  52. Herrmann T, Waanders GA, Chvatchko Y, MacDonald HR: The viral superantigen Mls-la induces interferon γ secretion by specifically primed CD8+ cells but fails to trigger cytotoxicity. Eur J Immunol 1992;22:2789–2793.

    Article  PubMed  CAS  Google Scholar 

  53. Stohl W, Elliott JE, Linsley PS: Human T cell-dependent B cell differentiation induced by staphylococcal superantigens. J Immunol 1994;153:117–127.

    PubMed  CAS  Google Scholar 

  54. Poindexter NJ, Schlievert PM: Suppression of immunoglobulinsecreting cells from human peripheral blood by toxic shock syndrome toxin-1. J Infect Dis 1986;153:772–779.

    PubMed  CAS  Google Scholar 

  55. Mourad W, Mehindate K, Schall T, McColl S: Engagement of MHC class II molecules by superantigen induces inflammatory cytokine gene expression in human rheumatoid fibroblast-like synoviocytes. J Exp Med 1992;175:613–616.

    Article  PubMed  CAS  Google Scholar 

  56. Hodoval LF, Morris EL, Crawley GJ, Beisel WR: Pathogenesis of lethal shock after intravenous staphylococcal enterotoxin B in monkeys. Appl Microbiol 1968;16: 187–192.

    PubMed  CAS  Google Scholar 

  57. Scheuber PH, Golecki JR, Kickhofen B, et al: Cysteinyl leukotrienes as mediators of staphylococcal enterotoxin B in the monkey. Eur J Clin Invest 1987; 17:455–459.

    Article  PubMed  CAS  Google Scholar 

  58. Harris TO, Grossman D, Kappler JW, et al: Lack of complete correlation between emetic and Tcellstimulatory activities of staphylococcal enterotoxins. Infect Immun 1993;61: 3175–3183.

    PubMed  CAS  Google Scholar 

  59. Schlievert PM: Role of superantigens in human disease. J Infect Dis 1993;167:997–1002.

    PubMed  CAS  Google Scholar 

  60. Krakauer T, Vilcek J, Oppenheim JJ: Proinflammatory cytokines: TNFβ and IL-1 families, chemokines,TGF\ and others; in Paul W (ed): Fundamental Immunology. New York, NY, Raven Press, 1998, pp. 775–811.

    Google Scholar 

  61. Sugiyama H, McKissic EM, Bergdoll MS, Heller B: Enhancement of bacterial endotoxin lethality by staphylococcal enterotoxin. J Infect Dis 1964;114:111–118.

    PubMed  CAS  Google Scholar 

  62. Stiles BG, Bavari S, Krakauer T, Ulrich RG: Toxicity of staphylococcal enterotoxins potentiated by lipopolysaccharide: major histocompatibility complex class II molecule dependency and cytokine release. Infect Immun 1993;61: 5333–5338.

    PubMed  CAS  Google Scholar 

  63. Chen JYJ, Qiao Y, Komisar JL, Baze WB, Hsu IC, Tseng J: Increased susceptibility to staphylococcal enterotoxin B intoxication in mice primed with actinomycin D. Infect Immun 1994;f62:4626–4631.

    Google Scholar 

  64. Sarawar SR, Blackman MA, Doherty PC: Superantigen shock in mice with an inapparent viral infection. J Infect Dis 1994;172: 1189–1194.

    Google Scholar 

  65. Miethke T, Wahl C, Heeg K, Echtenacher B, Krammer PH, Wagner H: T cell-mediated lethal shock triggered in mice by the superantigen SEB: critical role of TNF. J Exp Med 1992;175:91–98.

    Article  PubMed  CAS  Google Scholar 

  66. Hasko G, Virag L, Egnaczyk G, Salzman AL, Szabo C: The crucial role of IL-10 in the suppression of the immunological response in mice exposed to staphylococcal enterotoxins B. Eur J Immunol 1998; 28:1417–1425.

    Article  PubMed  CAS  Google Scholar 

  67. Stiles BG, Campbell YG, Castle RM, Grove SA: Murine studies with staphylococcal enterotoxin, toxic shock syndrome toxin-1, and streptococcal pyrogenic exotoxins: a temperature correlate of toxicity. Infect Immun 1999, 67: 1521–1525.

    PubMed  CAS  Google Scholar 

  68. Blank C, Luz A, Bendigs S, Erdmann A, Wagner H, and Heeg K: Superantigen and endotoxin syner gize in the induction of lethal shock. Eur J Immunol 1997; 27:825–833.

    Article  PubMed  CAS  Google Scholar 

  69. Saha B, Harlan DM, Lee KP, June CH, Abe R: Protection against lethal toxic shock by targeted disruption of the CD28 gene. J Exp Med 1996; 183:2675–2680.

    Article  PubMed  CAS  Google Scholar 

  70. Mittrucker HW, Shahinian A, Bouchard D, Kundig TM, Mak TW: Induction of unresponsiveness and impaired T cell expansion by staphylococcal enterotoxin B in CD28-deficient mice. J Exp Med 1996;183:2481–2486.

    Article  PubMed  CAS  Google Scholar 

  71. Manjunath N, Correa M, Ardman M, Ardman B: Negative regulation of T-cell adhesion and activation by CD43. Nature 1995; 377:535–538.

    Article  PubMed  CAS  Google Scholar 

  72. Mountz JD, Baker TJ, Borcherding DR, Bluethmann H, Zhou T, Edwards CK: Increased susceptibility of Fas mutant MRL-lpr/lpr mice to staphylococcal enterotoxin B-induced septic shock. J Immunol 1995;155:4829–4837.

    PubMed  CAS  Google Scholar 

  73. Sunstedt A, Grundstrom S, Dholsten M: T celland perforindependent depletion of B cells in vivo by staphylococcal enterotoxin A. Immunology 1998;95:76–82.

    Article  Google Scholar 

  74. MacDonald HR, Lees R, Baschieri S et al: Peripheral T cell reactivity to bacterial superantigensin vivo: the response/anergy paradox. Immunol Rev 1993;133:105–117.

    Article  PubMed  CAS  Google Scholar 

  75. Florquin S, Amraoui Z, Goldman M. T cells made deficient in IL-2 production by exposure to staphylococcal enterotoxin B in vivo are primed for interferon and IL-10 secretion. Eur J Immunol 1995; 25:1148–1153.

    Article  PubMed  CAS  Google Scholar 

  76. Schwab JH, Brown RR, Anderle SK, Schlievert PM: Superantigen can reactivate bacterial cell wall-induced arthritis. J Immunol 1993; 150, 4131–4138.

    Google Scholar 

  77. Abdelnour AT, Bremell T, Tarkowski A: TSST-l contributes to the arthritogenecity ofStaphylococcus aureus. J Infect Dis 1994;170:94–99.

    PubMed  CAS  Google Scholar 

  78. Brocke S, Gaur A, Piercy C, Gautam A, Gijbels K, Fathman CG, Steinman L: Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen. Nature 1993;365:642–645.

    Article  PubMed  CAS  Google Scholar 

  79. Leung DYM, Meissner HC, Fulton DR, Murray DL, Kotzin BL, Schlievert PM: Toxic shock syndrome toxin-secretingStaphylococcus aureus in Kawasaki syndrome. Lancet 1993;342:1385–1388.

    Article  PubMed  CAS  Google Scholar 

  80. Leclaire RD, Kell W, Bavari S, Smith T, Hunt RE: Protective effects of niacinamide in staphylococcal enterotoxin B induced toxicity. Toxicology 1996;107:69–81.

    Article  PubMed  CAS  Google Scholar 

  81. Saha B, Jaklic B, Harlan DM et al: Toxic shock syndrome-1-induced death is prevented by CTLA4Ig. J Immunol 1996;157:3869–3875.

    PubMed  CAS  Google Scholar 

  82. Stiles BG, Krakauer T, Bonventre PF: Biological activity of toxic shock syndrome toxin 1 and a site-directed mutant, H135A, in a lipopoly saccharide-potentiated mouse lethality model. Infect Immun 1995;63:1229–1234.

    PubMed  CAS  Google Scholar 

  83. Woody MA, Krakauer T, Ulrich RG, Stiles BG: Differential immune responses to staphylococcal enterotoxin B mutations in a hydrophobic loop dominating the interface with major histocompatibility complex class II receptors. J Infect Dis 1998;1013-1022.

  84. Bean AGD, Freiberg RA, Andrade S, et al.: Interleukin 10 protects mice against staphylococcal enterotoxin B-induced lethal shock. 1993;61:4937–4939.

    CAS  Google Scholar 

  85. Huang WT, Lin MT, Won SJ: Staphylococcal enterotoxin Ainduced fever is associated with increased circulating levels of cytokines in rabbits. Infect Immun 1997;65;2656–2662.

    PubMed  CAS  Google Scholar 

  86. Rott O, Fleischer B: A superantigen as a virulence factor in an acute bacterial infection. J Infect Dis 1994;169:1142–1145.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krakauer, T. Immune response to staphylococcal superantigens. Immunol Res 20, 163–173 (1999). https://doi.org/10.1007/BF02786471

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02786471

Key words

Navigation